M-Xylene

M-Xylene

SCHEMBL1420161

Cc1cccc(C)c1.c1ccc(-c2cccc(-c3ccccc3)c2)cc1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.63
MAOA P21397 1/20 0.54
TSHR P16473 2/20 0.50
LMNA P02545 1/20 0.50
ALOX12 P18054 1/20 0.50
NPC1 O15118 1/20 0.50
HPGD P15428 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.48
ALDH1A1 P00352 2/20 0.47
POLB P06746 1/20 0.47
MAPT P10636 1/20 0.47
CTDSP1 Q9GZU7 1/20 0.47
KMO O15229 1/20 0.46
DHODH Q02127 1/20 0.46
ENPP3 O14638 1/20 0.44
MAPK1 P28482 1/20 0.44
MEN1 O00255 1/20 0.44
ESR1 P03372 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19503240 0.95 TSHR (0.55) ACHEMAOATSHRLMNAALOX12
Biphenyl SCHEMBL28957955 0.95 ACHE (0.71) ACHEMAOATSHRLMNAALOX12
SCHEMBL28043537 0.92 TSHR (0.53) ACHEMAOATSHRLMNAALOX12
Benzene SCHEMBL27980187 0.92 ACHE (0.58) ACHEMAOATSHRLMNAALOX12
SCHEMBL28376833 0.92 MAOA (0.56) ACHEMAOATSHRLMNAALOX12
SCHEMBL200730 0.92 ACHE (0.58) ACHEMAOATSHRLMNAALOX12
Toluene SCHEMBL1998096 0.92 ACHE (0.61) ACHEMAOATSHRLMNAALOX12
Tannin Pyrogallol SCHEMBL1420026 0.92 ACHE (0.67) ACHEMAOATSHRLMNAALOX12
SCHEMBL29699277 0.92 ACHE (0.58) ACHEMAOATSHRLMNAALOX12
SCHEMBL9083578 0.90 ACHE (0.57) ACHEMAOATSHRLMNAALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399880-B2 Heteroarylamine compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2013-03-19 US disclosed
US-8283057-B2 Heteroarylamine compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2012-10-09 US disclosed
EP-2298740-A1 1-H-benzo[g]indole compounds and organic lightemitting device including the same Samsung Mobile Display Co., Ltd. (KR) 2011-03-23 EP disclosed
EP-2298737-A1 Indole compounds and organic light-emitting device including the same Samsung Mobile Display Co., Ltd. (KR) 2011-03-23 EP disclosed
US-20110049494-A1 HETEROARYLAMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2011-03-03 US disclosed
US-20110049484-A1 HETEROARYLAMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110049494-A1 HETEROARYLAMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME INMT, TYR, HTT ACHE 56/4885MAOA 53/4885TSHR 2623/4885
US-20110049484-A1 HETEROARYLAMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME INMT, TYR, HTT ACHE 56/4885MAOA 53/4885TSHR 2623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.